WO1996033744A3 - Compositions in glassy phase, stabilised by a sugar - Google Patents
Compositions in glassy phase, stabilised by a sugar Download PDFInfo
- Publication number
- WO1996033744A3 WO1996033744A3 PCT/GB1996/001014 GB9601014W WO9633744A3 WO 1996033744 A3 WO1996033744 A3 WO 1996033744A3 GB 9601014 W GB9601014 W GB 9601014W WO 9633744 A3 WO9633744 A3 WO 9633744A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sugar
- stabilised
- compositions
- glassy phase
- amorphous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Glass Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96912104A EP0836483A2 (en) | 1995-04-28 | 1996-04-26 | Compositions in glassy phase, stabilised by a sugar |
JP8532283A JPH11504035A (en) | 1995-04-28 | 1996-04-26 | Composition of glass phase stabilized by sugar |
CA002218929A CA2218929C (en) | 1995-04-28 | 1996-04-26 | Compositions in glassy phase, stabilised by a sugar |
AU55056/96A AU710039B2 (en) | 1995-04-28 | 1996-04-26 | Compositions in glassy phase, stabilised by a sugar |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9508691.4A GB9508691D0 (en) | 1995-04-28 | 1995-04-28 | Stable compositions |
GB9508691.4 | 1995-04-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996033744A2 WO1996033744A2 (en) | 1996-10-31 |
WO1996033744A3 true WO1996033744A3 (en) | 1996-12-19 |
Family
ID=10773701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1996/001014 WO1996033744A2 (en) | 1995-04-28 | 1996-04-26 | Compositions in glassy phase, stabilised by a sugar |
Country Status (7)
Country | Link |
---|---|
US (2) | US6071428A (en) |
EP (1) | EP0836483A2 (en) |
JP (1) | JPH11504035A (en) |
AU (1) | AU710039B2 (en) |
CA (1) | CA2218929C (en) |
GB (1) | GB9508691D0 (en) |
WO (1) | WO1996033744A2 (en) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU659645B2 (en) * | 1991-06-26 | 1995-05-25 | Inhale Therapeutic Systems | Storage of materials |
US6673335B1 (en) * | 1992-07-08 | 2004-01-06 | Nektar Therapeutics | Compositions and methods for the pulmonary delivery of aerosolized medicaments |
US6582728B1 (en) * | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
KR100291620B1 (en) * | 1992-09-29 | 2001-10-24 | 추후제출 | Methods of delivery through the lungs of active fragments of parathyroid hormone |
US20030113273A1 (en) * | 1996-06-17 | 2003-06-19 | Patton John S. | Methods and compositions for pulmonary delivery of insulin |
KR100419037B1 (en) * | 1994-03-07 | 2004-06-12 | 넥타르 테라퓨틱스 | Methods of delivery of insulin through the lungs and their composition |
CN1073119C (en) * | 1994-05-18 | 2001-10-17 | 吸入治疗系统公司 | Method and compositions for the dry powder formulation of interferons |
US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
US6258341B1 (en) * | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
US6309671B1 (en) | 1995-04-14 | 2001-10-30 | Inhale Therapeutic Systems | Stable glassy state powder formulations |
GB9705588D0 (en) * | 1997-03-18 | 1997-05-07 | Anglia Research Foundation | Stable particle in liquid formulations |
US20030035778A1 (en) * | 1997-07-14 | 2003-02-20 | Robert Platz | Methods and compositions for the dry powder formulation of interferon |
US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
US6309623B1 (en) * | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
GB9726343D0 (en) * | 1997-12-13 | 1998-02-11 | Auffret Anthony | The use of excipients to accelerate freeze-drying |
US6234167B1 (en) | 1998-10-14 | 2001-05-22 | Chrysalis Technologies, Incorporated | Aerosol generator and methods of making and using an aerosol generator |
US6630121B1 (en) | 1999-06-09 | 2003-10-07 | The Regents Of The University Of Colorado | Supercritical fluid-assisted nebulization and bubble drying |
MY136453A (en) * | 2000-04-27 | 2008-10-31 | Philip Morris Usa Inc | "improved method and apparatus for generating an aerosol" |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US7442388B2 (en) | 2000-05-10 | 2008-10-28 | Weers Jeffry G | Phospholipid-based powders for drug delivery |
US20020106368A1 (en) * | 2000-07-28 | 2002-08-08 | Adrian Bot | Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the same |
US20090004240A1 (en) * | 2000-08-11 | 2009-01-01 | Celonova Biosciences, Inc. | Implants with a phosphazene-containing coating |
US7077130B2 (en) * | 2000-12-22 | 2006-07-18 | Chrysalis Technologies Incorporated | Disposable inhaler system |
US6501052B2 (en) | 2000-12-22 | 2002-12-31 | Chrysalis Technologies Incorporated | Aerosol generator having multiple heating zones and methods of use thereof |
US6491233B2 (en) | 2000-12-22 | 2002-12-10 | Chrysalis Technologies Incorporated | Vapor driven aerosol generator and method of use thereof |
US6681998B2 (en) | 2000-12-22 | 2004-01-27 | Chrysalis Technologies Incorporated | Aerosol generator having inductive heater and method of use thereof |
US6701921B2 (en) * | 2000-12-22 | 2004-03-09 | Chrysalis Technologies Incorporated | Aerosol generator having heater in multilayered composite and method of use thereof |
US6799572B2 (en) | 2000-12-22 | 2004-10-05 | Chrysalis Technologies Incorporated | Disposable aerosol generator system and methods for administering the aerosol |
US7101693B2 (en) * | 2001-09-07 | 2006-09-05 | Brigham Young University | Plasticized hydrophilic glasses for improved stabilization of biological agents |
US6640050B2 (en) | 2001-09-21 | 2003-10-28 | Chrysalis Technologies Incorporated | Fluid vaporizing device having controlled temperature profile heater/capillary tube |
US6568390B2 (en) | 2001-09-21 | 2003-05-27 | Chrysalis Technologies Incorporated | Dual capillary fluid vaporizing device |
US6804458B2 (en) | 2001-12-06 | 2004-10-12 | Chrysalis Technologies Incorporated | Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate |
US6681769B2 (en) | 2001-12-06 | 2004-01-27 | Crysalis Technologies Incorporated | Aerosol generator having a multiple path heater arrangement and method of use thereof |
CA2468958C (en) | 2001-12-19 | 2012-07-03 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
US6701922B2 (en) | 2001-12-20 | 2004-03-09 | Chrysalis Technologies Incorporated | Mouthpiece entrainment airflow control for aerosol generators |
RU2418633C2 (en) * | 2004-04-08 | 2011-05-20 | Байоматрика, Инк. | Integration of specimens storage and control in biomedical sciences |
US20060099567A1 (en) * | 2004-04-08 | 2006-05-11 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
US20080176209A1 (en) * | 2004-04-08 | 2008-07-24 | Biomatrica, Inc. | Integration of sample storage and sample management for life science |
US20060039985A1 (en) * | 2004-04-27 | 2006-02-23 | Bennett David B | Methotrexate compositions |
US20070031342A1 (en) * | 2005-06-22 | 2007-02-08 | Nektar Therapeutics | Sustained release microparticles for pulmonary delivery |
JP5214464B2 (en) | 2005-12-28 | 2013-06-19 | アドバンスド バイオニュートリション コーポレーション | Delivery medium for probiotic bacteria, in the form of glass, comprising a dry matrix of polysaccharides, saccharides and polyols and method for producing the same |
US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
AU2007234612B2 (en) * | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
WO2008076975A1 (en) | 2006-12-18 | 2008-06-26 | Advanced Bionutrition Corporation | A dry food product containing live probiotic |
WO2008129937A1 (en) * | 2007-04-13 | 2008-10-30 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Multilayer structure for oral applications and method for production thereof |
US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
EP2187932B1 (en) | 2007-08-07 | 2015-01-28 | DePuy Synthes Products, LLC | Protein formulations comprising gdf-5 in aqueous acidic solution |
WO2009129101A1 (en) | 2008-04-14 | 2009-10-22 | Advanced Technologies And Regenerative Medicine, Llc | Liquid buffered gdf-5 formulations |
CA2986751A1 (en) | 2009-03-27 | 2010-09-30 | Intervet International B.V. | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
JP5841527B2 (en) | 2009-05-26 | 2016-01-13 | アドバンスド バイオニュートリション コーポレーション | Stable dry powder composition comprising biologically active microorganisms and / or bioactive materials and method for producing the same |
JP5721704B2 (en) | 2009-06-12 | 2015-05-20 | マイクロニクス, インコーポレイテッド | Rehydratable matrix for dry storage of TAQ polymerase in microfluidic devices |
AU2010258716B2 (en) | 2009-06-12 | 2015-11-12 | Perkinelmer Health Sciences, Inc. | Compositions and methods for dehydrated storage of on-board reagents in microfluidic devices |
CN102725393B (en) * | 2010-01-28 | 2015-12-02 | 先进生物营养公司 | Comprise the dry glass matter composition of biological active materials |
US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
EP2598660B1 (en) | 2010-07-26 | 2017-03-15 | Biomatrica, INC. | Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures |
EP2598661B1 (en) | 2010-07-26 | 2017-09-27 | Biomatrica, INC. | Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures |
SG187250A1 (en) | 2010-08-13 | 2013-03-28 | Advanced Bionutrition Corp | Dry storage stabilizing composition for biological materials |
US9725703B2 (en) | 2012-12-20 | 2017-08-08 | Biomatrica, Inc. | Formulations and methods for stabilizing PCR reagents |
WO2015191632A1 (en) | 2014-06-10 | 2015-12-17 | Biomatrica, Inc. | Stabilization of thrombocytes at ambient temperatures |
DK3328215T3 (en) | 2015-07-29 | 2021-09-13 | Advanced Bionutrition Corp | STABLE DRY PROBIOTIC COMPOSITIONS FOR SPECIFIC DIETARY USES |
PL3344048T3 (en) * | 2015-09-01 | 2021-10-25 | Koninklijke Douwe Egberts B.V. | Method for preparing dairy powder |
CN113588501A (en) | 2015-12-08 | 2021-11-02 | 生物马特里卡公司 | Reducing erythrocyte sedimentation rate |
CA2986535A1 (en) * | 2017-10-18 | 2019-04-18 | Quanta Associates, L.P. | Systems and methods for drying and cleaning an aerial lift electrically insulated boom |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987000196A1 (en) * | 1985-07-09 | 1987-01-15 | Quadrant Bioresources Limited | Protection of proteins and the like |
WO1990005182A1 (en) * | 1988-11-11 | 1990-05-17 | Cranfield Biotechnology Ltd. | Enzyme stabilisation |
EP0383569A2 (en) * | 1989-02-16 | 1990-08-22 | Pafra Limited | Storage of materials |
EP0520748A1 (en) * | 1991-06-26 | 1992-12-30 | Pafra Limited | Storage of materials |
WO1993014191A1 (en) * | 1992-01-21 | 1993-07-22 | Cryopharm Corporation | Method of freezing cells and cell-like materials |
WO1996003978A1 (en) * | 1994-08-04 | 1996-02-15 | Quadrant Holdings Cambridge Limited | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1855591A (en) * | 1926-02-03 | 1932-04-26 | Wallerstein Co Inc | Invertase preparation and method of making the same |
US3300474A (en) * | 1964-02-12 | 1967-01-24 | Pharmacia Ab | Sucrose ether copolymerizates |
US4267703A (en) * | 1977-02-22 | 1981-05-19 | Groen Division - Dover Corporation | Method and apparatus for manufacturing crystalline food products |
DE2748132A1 (en) * | 1977-10-27 | 1979-05-03 | Behringwerke Ag | STABILIZER FOR POLYSACCHARIDE |
EP0111216A3 (en) * | 1980-03-31 | 1985-01-16 | Takeda Chemical Industries, Ltd. | Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor |
DE3141498A1 (en) * | 1981-10-20 | 1983-04-28 | Bayer Ag, 5090 Leverkusen | Pharmaceutical containing kallikrein and process for its preparation |
US4457916A (en) * | 1982-08-31 | 1984-07-03 | Asahi Kasei Kogyo Kabushiki Kaisha | Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same |
JPS6092299A (en) * | 1983-10-25 | 1985-05-23 | Sanwa Kosan Kk | Production of powdery maltose |
US4892745A (en) * | 1984-05-03 | 1990-01-09 | The Procter & Gamble Co. | Texture equilibration in cookies |
JPS60244288A (en) * | 1984-05-18 | 1985-12-04 | Ookura Seiyaku Kk | Preparation of stable serrapeptase powder |
DK8502857A (en) * | 1984-06-25 | 1985-12-26 | ||
GB8500698D0 (en) * | 1985-01-11 | 1985-02-13 | Unilever Plc | Preparation of reagents |
DE3541186A1 (en) * | 1985-11-21 | 1987-05-27 | Boehringer Mannheim Gmbh | WATER-SOLUBLE, STABILIZED PEROXIDASE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USE FOR DETERMINING HYDROGEN PEROXIDE |
GB8604983D0 (en) * | 1986-02-28 | 1986-04-09 | Biocompatibles Ltd | Protein preservation |
US4753816A (en) * | 1987-05-20 | 1988-06-28 | Nabisco Brands, Inc. | Fruit juice based hard candy |
JP2518646B2 (en) * | 1987-05-29 | 1996-07-24 | 株式会社 林原生物化学研究所 | Method for producing maltose powder |
US5023092A (en) * | 1988-06-16 | 1991-06-11 | Ici Americas Inc. | Mannitol having gamma sorbitol polymorph |
GB9010742D0 (en) * | 1990-05-14 | 1990-07-04 | Quadrant Bioresources Ltd | Stabilization of biological macromolecular substances |
DK0480519T3 (en) * | 1990-10-12 | 1996-06-24 | Duphar Int Res | Solid lactulose |
JPH04271785A (en) * | 1991-02-28 | 1992-09-28 | Kao Corp | Enzymic solid pharmaceutical and its production |
IT1254359B (en) * | 1992-05-11 | 1995-09-14 | Serono Cesare Ist Ricerca | PHARMACEUTICAL COMPOSITIONS CONTAINING IL-6 |
TW402506B (en) * | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
JPH0733666A (en) * | 1993-07-27 | 1995-02-03 | Kyowa Hakko Kogyo Co Ltd | Method of stabilizing indolocarbazole derivative |
US5549757A (en) * | 1994-06-10 | 1996-08-27 | Ingredient Technology Corporation | Process for recrystallizing sugar and product thereof |
-
1995
- 1995-04-28 GB GBGB9508691.4A patent/GB9508691D0/en active Pending
-
1996
- 1996-04-26 WO PCT/GB1996/001014 patent/WO1996033744A2/en active Application Filing
- 1996-04-26 JP JP8532283A patent/JPH11504035A/en not_active Ceased
- 1996-04-26 EP EP96912104A patent/EP0836483A2/en not_active Ceased
- 1996-04-26 CA CA002218929A patent/CA2218929C/en not_active Expired - Fee Related
- 1996-04-26 AU AU55056/96A patent/AU710039B2/en not_active Ceased
- 1996-04-26 US US08/638,479 patent/US6071428A/en not_active Expired - Fee Related
-
2000
- 2000-05-22 US US09/576,167 patent/US6503411B1/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987000196A1 (en) * | 1985-07-09 | 1987-01-15 | Quadrant Bioresources Limited | Protection of proteins and the like |
WO1990005182A1 (en) * | 1988-11-11 | 1990-05-17 | Cranfield Biotechnology Ltd. | Enzyme stabilisation |
EP0383569A2 (en) * | 1989-02-16 | 1990-08-22 | Pafra Limited | Storage of materials |
EP0520748A1 (en) * | 1991-06-26 | 1992-12-30 | Pafra Limited | Storage of materials |
WO1993014191A1 (en) * | 1992-01-21 | 1993-07-22 | Cryopharm Corporation | Method of freezing cells and cell-like materials |
WO1996003978A1 (en) * | 1994-08-04 | 1996-02-15 | Quadrant Holdings Cambridge Limited | Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
Non-Patent Citations (2)
Title |
---|
CARPENTER J.F. ET AL: "Separation of freezing- and drying -induced denaturation of lyophilized proteins using stress-specific stabilization: I. Enzyme activity and calorimetric studies", ARCH. BIOCHEM. BIOPHYS., 1993, VOL. 303, NO. 2, PAGE(S) 456-464, XP002017577 * |
LIPPERT K. ET AL: "Enzyme stabilization by ectoine-type compatible solutes: Protection against heating, freezing and drying", APPL. MICROBIOL. BIOTECHNOL., 1992, VOL. 37, NO. 1, PAGE(S) 61-65, XP000608489 * |
Also Published As
Publication number | Publication date |
---|---|
EP0836483A2 (en) | 1998-04-22 |
WO1996033744A2 (en) | 1996-10-31 |
GB9508691D0 (en) | 1995-06-14 |
CA2218929A1 (en) | 1996-10-31 |
JPH11504035A (en) | 1999-04-06 |
AU710039B2 (en) | 1999-09-09 |
US6071428A (en) | 2000-06-06 |
US6503411B1 (en) | 2003-01-07 |
AU5505696A (en) | 1996-11-18 |
CA2218929C (en) | 2008-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996033744A3 (en) | Compositions in glassy phase, stabilised by a sugar | |
AU6601894A (en) | Non-reducing oligosaccharide and its production and use | |
WO1991006367A3 (en) | Zeolite l | |
EP0771835A3 (en) | Polyalkoxysiloxane and process for its production | |
WO1999004774A3 (en) | Nucleotide analog compositions | |
AU5066893A (en) | Mixed zeolites and method for producing same | |
CA2338354A1 (en) | Li2o-al2o3-sio2 type transparent crystallized glass and crytallizable glass | |
IE871730L (en) | Calcium compositions | |
AU5227990A (en) | Gas generant compositions containing salts of 5-n1 trobarbituric acid, salts of nitroorotic acid, or 5-nitrouracil | |
WO2000015018A3 (en) | Method for preparation of the supersaturated solution of calcium phosphate and the thin film of calcium phosphate crystal by using the solution | |
CA2287530A1 (en) | Aluminosilicate compositions, preparation and use | |
CA2429639A1 (en) | Stable azithromycin monohydrate | |
CA2209146A1 (en) | Microporous crystalline material, a process for its preparation and its use in detergent compositions | |
WO2001090137A3 (en) | NOVEL SOLID BODY FORMS OF MESOPROGESTIN 11β-[4E-(HYDROXYIMINOMETHYL)-PHENYL]-17α-METHOXYMETHYL-17β-METHOXY-ESTRA-4,9-DIEN-3-ONE | |
EP0396155A3 (en) | Glass ceramic dielectric compositions | |
MX9703879A (en) | Preparation of ice crystals suspension in sugar solution and its use for making confections. | |
WO2001008671A3 (en) | Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses | |
AU1485192A (en) | Crop-protecting compositions containing isoxazolines or isothiazolines, novel isoxazolines and isothiazolines, and their preparation | |
CA2392088A1 (en) | Fertiliser additive comprising magnesium and calcium sulphate and carbonate | |
EP1270572A4 (en) | Condensed pyrazole derivatives, process for producing the same and use thereof | |
EP1420025A4 (en) | Powder comprising water-containing beta-maltose crystals and production process and use thereof | |
AU2001255321A1 (en) | Cementitious composition containing glass powder as a pozzolan | |
ZA946203B (en) | Thermodynamically stable crystal form of 4"-deoxy-4"-epi-methylamino avermectin B1a/B1b benzoic acid salt and processes for its preparation | |
Szabo | CRYSTALLISATION OF FLUORIDE GLASSES | |
AU4036199A (en) | Stabilised compositions containing hyaluronic acid, their preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2218929 Country of ref document: CA Ref country code: CA Ref document number: 2218929 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1996 532283 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996912104 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1996912104 Country of ref document: EP |